ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP08

Learning to Advocate for Myself and the Young Adult Community While Finding My Place as a Patient Partner at CARRA (Childhood Arthritis and Rheumatology Research Alliance)

Ela Chintagunta1, Courtney Wells2 and Kristine Carandang3, 1Young Patients' Autoimmune Research & Empowerment Alliance, Chicago, IL, 2University of Wisconsin-River Falls; Young Patients' Autoimmune Research and Empowerment Alliance, St. Paul, MN, 3Young Patients' Autoimmune Research & Empowerment Alliance, San Diego, CA

Meeting: ACR Convergence 2022

Keywords: Juvenile idiopathic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Patient Perspectives Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: I was diagnosed with Juvenile Idiopathic Arthritis at the age of 13 when I was experiencing joint swelling in my lower body and my hands. I was lucky that I was in medicated remission quickly. Being diagnosed with a health condition that has unknown causes or a cure, I wanted to know what kind of research was being conducted to help with finding causes or cures, as well as increasing daily quality of life and knowledge. I wanted to help other young adults who were going through the process of getting diagnosed and receiving treatment to know that they can stand up for themselves and become a stronger and more resilient person.

Intervention: CARRA is an organization of healthcare professionals and researchers working together to research, facilitate, and accelerate the understanding of the epidemiology, outcomes and biology of pediatric rheumatic diseases. Patients and caregivers collaborate with CARRA members to prioritize, design, conduct, and share results of their research. CARRA is organized in disease specific research committees and within those research committees are workgroups. Since February 2021, I have joined 6 CARRA workgroups as a patient partner working on projects I found interesting or pertinent to my life. My role is to bring the patient’s voice to the table and think about what the patient cares about through discussions and feedback on materials and study design. I was even asked to write an article about my experiences at meetings for the CARRA registry newsletter.

Maintenance: Being a patient partner has empowered me to advocate for myself and others, even as a young adult. At the beginning of my time with CARRA, I felt that because I do not have medical training or other advanced knowledge like clinicians and researchers, I could not be useful. I learned quickly that what I do have is my lived experience with JIA and my unique viewpoint that makes a difference in how research is conducted. As I realized my value, I began sticking up for myself in meetings when workload was a lot or meeting times were inconvenient with school. It was important to me that both parties – clinicians/researchers and patients – were heard and benefitting equally from a bilateral exchange, with me gaining knowledge about research in rheumatology, as well as networking opportunities for my career. This information and my advocacy skills translated into me being empowered to bring new ideas on how to improve my lifestyle and treatment to my own rheumatology provider as well as help other patients to advocate.

Quality of Life: I am still in medicated remission trying to get off medication, but arthritis still affects my daily life and leaves me to advocate for myself. One way is working on projects with the Arthritis Foundation, providing young adult patient input to legislation and programming. I am also a member of Young Patients’ Autoimmune Research and Empowerment Alliance (YP AREA), where we aim to empower adolescents and young adults (AYAs) to engage further with research to improve their care and daily lives. Finally, I am a user expert/Access Leader at my college working on providing feedback about spaces and experiences from a disability standpoint.


Disclosures: E. Chintagunta, None; C. Wells, None; K. Carandang, None.

To cite this abstract in AMA style:

Chintagunta E, Wells C, Carandang K. Learning to Advocate for Myself and the Young Adult Community While Finding My Place as a Patient Partner at CARRA (Childhood Arthritis and Rheumatology Research Alliance) [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/learning-to-advocate-for-myself-and-the-young-adult-community-while-finding-my-place-as-a-patient-partner-at-carra-childhood-arthritis-and-rheumatology-research-alliance/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/learning-to-advocate-for-myself-and-the-young-adult-community-while-finding-my-place-as-a-patient-partner-at-carra-childhood-arthritis-and-rheumatology-research-alliance/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology